DDB2 and glioblastoma: Several abnormally expressed-DDR genes, including exonuclease 1 (EXO1), nei-like DNA glycosylase 3 (NEIL3), and DNA damage-binding protein 2 (DDB2), are associated with GBM progression and susceptibility [13].